Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Plos One|November 1, 2011
A comparison of parallel pyrosequencing and sanger clone-based sequencing and its impact on the characterization of the genetic diversity of HIV-1Binhua Liang, Ma Luo, Joel Scott-Herridge, et al.
Nature Communications|June 10, 2022
Expansion of cytotoxic tissue-resident CD8<sup>+</sup> T cells and CCR6<sup>+</sup>CD161<sup>+</sup> CD4<sup>+</sup> T cells in the nasal mucosa following mRNA COVID-19 vaccinationAloysious Ssemaganda, Huong Mai Nguyen, Faisal Nuhu, et al.
Plos One|June 18, 2016
Genetic Characterization of a Panel of Diverse HIV-1 Isolates at Seven International SitesBhavna Hora, Sheila M Keating, Yue Chen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 11, 2025
HIV Drug Resistance Among Key Populations in Nigeria: Insights From the 2020 Integrated Biological and Behavioral Surveillance SurveyStephanie Melnychuk, Kalada Green, Chukwuebuka Ejeckam, et al.
Scientific Reports|February 2, 2020
Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testingEmma R Lee, Neil Parkin, Cheryl Jennings, et al.
The Lancet. HIV|September 24, 2016
Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO surveySantiago Ávila-Ríos, Claudia García-Morales, Margarita Matías-Florentino, et al.
AIDS (London, England)|February 3, 2021
Rectal microbiota diversity in Kenyan MSM is inversely associated with frequency of receptive anal sex, independent of HIV statusHenok Gebrebrhan, Cheli Kambaran, Aida Sivro, et al.
Viruses|July 2, 2020
Multi-Laboratory Comparison of Next-Generation to Sanger-Based Sequencing for HIV-1 Drug Resistance GenotypingNeil T Parkin, Santiago Avila-Rios, David F Bibby, et al.
Frontiers in Immunology|April 11, 2025
Improved antibody breadth with an extended primary dose interval of COVID-19 vaccine is overcome by boostersJessica I Ahmed, Samantha J Krosta, Mandy N Reimer, et al.
Pageof 4